Metsera, Inc.

YTD

ALL

Trade Metsera, Inc. 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MTSR

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.

CEO

Christopher Whitten Bernard

CEOChristopher Whitten Bernard

Employees

Employees81

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2022

Founded2022

Employees

Employees81

MTSR Key Statistics

Market cap

5.57B

Market cap5.57B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.54M

Average volume1.54M

High today

$53.05

High today$53.05

Low today

$52.59

Low today$52.59

Open price

$52.61

Open price$52.61

Volume

1.12M

Volume1.12M

52 Week high

$54.47

52 Week high$54.47

52 Week low

$12.30

52 Week low$12.30

MTSR News

TipRanks 12h

Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer

New activity is brewing for Metsera, Inc. ( (MTSR) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gi...

People also own

Based on the portfolios of people who own MTSR. This list is generated using Robinhood data, and it’s not a recommendation.